UNLOXCYT (cosibelimab-ipdl) is indicated for the treatment of adults with metastatic cutaneous squamous cell carcinoma (“cSCC”) or locally advanced cSCC who are not candidates for curative surgery or ...
"This would occur only after achieving security and political stability in Syria, completing the political transition process, and establishing the political system that Syrians aspire to build," Moha ...